April 26, 2018
ASA: Anesthesia drug shortages affecting patient care
Editor's Note
The American Society of Anesthesiologists (ASA) on April 25 reported that a national drug shortage of injectable opioids and local anesthetics is negatively affecting care received by patients under anesthesia.
An informal survey of 2,500 ASA members, found that 98% are now experiencing drug shortages at their institutions, and more than 95% say the shortages are affecting the way they treat their patients.
The top five drugs in short supply are hydromorphone, fentanyl, morphine, bupivacaine, and epinephrine.
Free Daily News
- Catheter sterility concerns prompt Class 1 FDA recall for surgery trays
- Large amounts of personal data possibly stolen in Change Healthcare cyberattack
- AI model helps predict patient decline, drive collaborative care
- One patient’s recovery highlights benefits of outpatient endoscopic spine surgery
- Getting ready for the OAS CAHPS Survey 2025 requirement
- Contribute to perioperative education with the 2024 OR Manager Salary/Career Survey
- Supply chain stability improves, but threats remain
- Private equity healthcare ownership draws new scrutiny
- Share your expertise! Topics, speakers sought for 2025 ORBMC
- FDA approves imaging drug for detecting cancer after lumpectomy
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity, Equity, Inclusion & Belonging